Cargando…
Role of biomarkers in the diagnosis and prognosis of patients with cutaneous lupus erythematosus
Cutaneous lupus erythematosus (CLE) is a connective tissue disease with varying presentations, and clinical sequelae including itching, dyspigmentation, and scarring. CLE can occur as its own entity or in conjunction with systemic disease, known as systemic lupus erythematosus (SLE). Because CLE is...
Autores principales: | Zhu, Jane L., Black, Samantha M., Chong, Benjamin F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033322/ https://www.ncbi.nlm.nih.gov/pubmed/33842650 http://dx.doi.org/10.21037/atm-20-5232 |
Ejemplares similares
-
AB006. A modular analysis approach to studying gene expression in cutaneous lupus erythematosus
por: Zhu, Jane, et al.
Publicado: (2021) -
AB007. Worse skin disease severity may distinguish patients who progress from cutaneous lupus erythematous to systemic lupus erythematous
por: Walocko, Frances, et al.
Publicado: (2021) -
AB001. Understanding transcriptional connections of chronic cutaneous lupus erythematosus between humans and animal models
por: Banovic, Frane, et al.
Publicado: (2021) -
AB002. Quality of life is inversely related to income in patients with cutaneous lupus
por: Prasad, Smriti, et al.
Publicado: (2021) -
AB005. Assessing meaningful changes in disease activity as clinical trial clinical efficacy measures for cutaneous lupus erythematosus
por: Chakka, Srita, et al.
Publicado: (2021)